fig4

From: Long-term impact of corticosteroid therapy on adult height in juvenile myasthenia gravis patients: a retrospective multicenter cohort study

Long-term impact of corticosteroid therapy on adult height in juvenile myasthenia gravis patients: a retrospective multicenter cohort study

Figure 4. Factors affecting lower final height than predicted. **Adult final-predicted height discrepancies was significantly correlated with GC initiation before puberty.

Rare Disease and Orphan Drugs Journal

ISSN 2771-2893 (Online)

Navigation

Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Discover Content

Strategic Collaborators

Follow OAE

Privacy Cookies Terms of Service